Description
DE-OBLIGATE EXCESS FUNDS.
Base award description: ROCHE COBAS 6800 HCV&HIV REAGENTS
Modification chain · 14 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-03-13+$1,350,106= $1,350,106
- Mod P000012018-03-10+$1,350,106= $2,700,212
- Mod P000022018-10-02+$896,828= $3,597,039
- Mod P000032019-02-05-$2,384= $3,594,655
- Mod P000042019-04-24-$978,220= $2,616,435
- Mod P000052020-01-31+$556,869= $3,173,305
- Mod P000062020-04-06+$706,800= $3,880,105
- Mod P000072020-04-20-$346,890= $3,533,214
- Mod P000082020-11-06+$142,320= $3,675,534
- Mod P000092021-03-09+$1,636,614= $5,312,148
- Mod P000102021-03-10+$32,760= $5,344,908
- Mod P000112021-03-31-$100,700= $5,244,208
- Mod P000122021-04-06-$96,170= $5,148,038
- Mod P000132022-06-23-$596,504= $4,551,533
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-03-13 | +$1,350,106 | $1,350,106 | ROCHE COBAS 6800 HCV&HIV REAGENTS |
| Mod P00001· EXERCISE AN OPTION | 2018-03-10 | +$1,350,106 | $2,700,212 | ROCHE COBAS 6800 HCV&HIV REAGENTS |
| Mod P00002· EXERCISE AN OPTION | 2018-10-02 | +$896,828 | $3,597,039 | ROCHE COBAS 6800 HCV&HIV REAGENTS |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-02-05 | −$2,384 | $3,594,655 | ROCHE COBAS 6800 HCV&HIV REAGENTS |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2019-04-24 | −$978,220 | $2,616,435 | ROCHE COBAS 6800 HCV&HIV REAGENTS DE-OBLIGATE EXCESS FUNDS. |
| Mod P00005· EXERCISE AN OPTION | 2020-01-31 | +$556,869 | $3,173,305 | EXERCISE OPTION YEAR THREE ROCHE COBAS 6800 HCV&HIV REAGENTS |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2020-04-06 | +$706,800 | $3,880,105 | COBAS SARS-COV-TEST KITS EMERGENCY ORDER |
| Mod P00007· OTHER ADMINISTRATIVE ACTION | 2020-04-20 | −$346,890 | $3,533,214 | DE-OBLIGATION OF EXCESS FUNDING PURCHASE ORDER 544-C95030 |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-11-06 | +$142,320 | $3,675,534 | PURCHASE ORDER 544-C15052 COBAS LIAT SYSTEM - COVID-19 RELATED |
| Mod P00009· EXERCISE AN OPTION | 2021-03-09 | +$1,636,614 | $5,312,148 | EXERCISE OPTION YEAR FOUR |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-03-10 | +$32,760 | $5,344,908 | EXERCISE OPTION YEAR FOUR - ADDITIONAL COVID -RELATED SUPPLIES. |
| Mod P00011· OTHER ADMINISTRATIVE ACTION | 2021-03-31 | −$100,700 | $5,244,208 | DE-OBLIGATE EXCESS FUNDS. |
| Mod P00012· OTHER ADMINISTRATIVE ACTION | 2021-04-06 | −$96,170 | $5,148,038 | DE-OBLIGATE EXCESS FUNDS. |
| Mod P00013· OTHER ADMINISTRATIVE ACTION | 2022-06-23 | −$596,504 | $4,551,533 | DE-OBLIGATE EXCESS FUNDS. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JDMDFEZBYH36)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0794 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $200,000 | FY2026 |
| 36C25026N0788 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $135,282 | FY2026 |
| 36C25726N0474 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $21,384 | FY2026 |
| 36C25726C0089 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · J066 · MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT | $46,948 | FY2026 |
| 36C25926N0437 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $35,030 | FY2026 |
| 36C25926N0438 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $34,878 | FY2026 |
Other recipients under 6550 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726P0530 | FIRST NATION GROUP LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $146,995 | FY2026 |
| 36C24726P0296 | CEPHEID | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $179,700 | FY2026 |
| 36C24725F0318 | QUIDELORTHO SALES COMPANY, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $294,875 | FY2025 |
| 36C24725P0739 | MAXCYTE, INC. | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $49,680 | FY2025 |
| 36C24725P0048 | POLYMEDCO LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $1,936,200 | FY2025 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24717P1127_3600_-NONE-_-NONE- · retrieved 2026-09-26.